Ascendis Pharma A/S (ASND) Form 6-K — Sep 9, 2026
Ascendis Pharma A/S disclosed that its board of directors granted an aggregate of 29,380 warrants to certain employees on September 8, 2026, under the terms of Appendix 1a to the company's Articles of Association. Each Warrant confers the right to subscribe for one ordinary share at an exercise price of US $270.09 per share, equal to the closing price on the date of grant. Vesting is 25% on the one-year anniversary of the grant, with the remaining 75% vesting at a rate of 1/36th per month beginning one year after grant, subject to continued service, and earlier vesting upon certain exit events.
Key figures
- Shares Outstanding
- 66380466
- Vesting schedule
- 25% at 1-year anniversary; remaining 75% at 1/36th per month from year 1, subject to continued service
- Warrants granted
- 29380
- Warrant exercise price usd
- 270.09
- Total warrants issued to date
- 13665720
- Warrants available for future grant
- 1495063
- Warrants exercised annulled or lapsed
- 9057394
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.